UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 326

Sortiert nach

Ratgeber Schmerzmittel: Substanzen, Indikationen, Nebenwirkungen

1st Aufl 2022nd edition, 2022

Volltextzugriff (PDF)

Ratgeber Schmerzmittel: Substanzen, Indikationen, Nebenwirkungen

1, 2022

Volltextzugriff (PDF)

We miss the opportunity: Pretreament of osteoporosis in a German trauma center

PloS one, 2018-11, Vol.13 (11), p.e0207122-e0207122

2018

Volltextzugriff (PDF)

Seronegative alveolar echinococcosis in a patient with multiple myeloma

International journal of infectious diseases, 2018-04, Vol.69, p.47-49

2018

Volltextzugriff (PDF)

Correspondence

Deutsches Ärzteblatt international, 2023-07

2023

Volltextzugriff (PDF)

Pain management in opioid maintenance treatment

Expert opinion on pharmacotherapy, 2019-11, Vol.20 (16), p.1993-2005

2019

Volltextzugriff (PDF)

Opioide in der Hausarztpraxis

MMW Fortschritte der Medizin, 2017-11, Vol.159 (Suppl 3), p.52-61

2017

Volltextzugriff (PDF)

Langzeiteffektivität topisch applizierter Analgetika

Schmerz (Berlin, Germany), 2020-02, Vol.34 (1), p.21-32

2020

Volltextzugriff (PDF)

Sleep-disordered breathing decreases after opioid withdrawal: results of a prospective controlled trial

Pain (Amsterdam), 2015-11, Vol.156 (11), p.2167-2174

2015

Volltextzugriff (PDF)

Binding of the cGMP-gated Channel to the Na/Ca-K Exchanger in Rod Photoreceptors

The Journal of biological chemistry, 2000-05, Vol.275 (18), p.13448-13454

2000

Volltextzugriff (PDF)

Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors

Journal of cancer research and clinical oncology, 2023-08, Vol.149 (10), p.6989-6998

2023

Volltextzugriff (PDF)

Prediction of early treatment failure of second-line nal-iri/5-FU/FA in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.721-721

2023

Volltextzugriff (PDF)

Opiates in the treatment of non-cancer-related pain

MMW Fortschritte der Medizin, 2011-05, Vol.153 (21), p.51-53

2011

Volltextzugriff (PDF)

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

Annals of hematology, 2023-11, Vol.102 (11), p.3083-3090

2023

Volltextzugriff (PDF)

Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain—Individualized or Fixed Starting Dosage?

Pain medicine (Malden, Mass.), 2019-12, Vol.20 (12), p.2438-2449

2019

Volltextzugriff (PDF)

Confusing and Substantially Overinterpreted

Deutsches Ärzteblatt international, 2023-07, Vol.120 (27-28), p.486-486

2023

Volltextzugriff (PDF)

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

The Lancet. Haematology, 2022-11, Vol.9 (11), p.e810-e821

2022

Volltextzugriff (PDF)

Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study

Journal of cancer research and clinical oncology, 2023-07, Vol.149 (7), p.3739-3752

2023

Volltextzugriff (PDF)

Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions

Leukemia, 2018-09, Vol.32 (9), p.2085-2087

2018

Volltextzugriff (PDF)

Long-term effectiveness of topical analgesics

Schmerz (Berlin, Germany), 2020-02, Vol.34 (1), p.21-32

2020

Volltextzugriff (PDF)

Induction with Bortezomib Melphalan and Prednisolon (VMP) Is Associated with Unexpectedly High Discontinuation Rate in Elderly Multiple Myeloma Patients: First Analysis of the German Maintenance (GERMAIN) Trial

Blood, 2018-11, Vol.132 (Supplement 1), p.2016-2016

2018

Volltextzugriff (PDF)

Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)

Journal of cancer research and clinical oncology, 2020-03, Vol.146 (3), p.749-759

2020

Volltextzugriff (PDF)

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Annals of hematology, 2019-04, Vol.98 (4), p.897-907

2019

Volltextzugriff (PDF)

Medication compliance in patients with chronic pain

Pain physician, 2014-01, Vol.17 (1), p.81-94

2014

Volltextzugriff (PDF)

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial

British journal of haematology, 2017-03, Vol.176 (5), p.770-782

2017

Volltextzugriff (PDF)

1 – 25 von 326

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(181)
Mit Volltextzugriff
(304)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(189)
Deutsch
(140)
Japanisch
(12)
Französisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Ratgeber Schmerzmittel: Substanzen, Indikationen, Nebenwirkungen

Ratgeber Schmerzmittel: Substanzen, Indikationen, Nebenwirkungen

We miss the opportunity: Pretreament of osteoporosis in a German trauma center

Seronegative alveolar echinococcosis in a patient with multiple myeloma

Correspondence

Pain management in opioid maintenance treatment

Opioide in der Hausarztpraxis

Langzeiteffektivität topisch applizierter Analgetika

Sleep-disordered breathing decreases after opioid withdrawal: results of a prospective controlled trial

Binding of the cGMP-gated Channel to the Na/Ca-K Exchanger in Rod Photoreceptors

Individual hematotoxicity prediction of further chemotherapy cycles by dynamic mathematical models in patients with gastrointestinal tumors

Prediction of early treatment failure of second-line nal-iri/5-FU/FA in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)

Opiates in the treatment of non-cancer-related pain

Treatment with idelalisib in patients with chronic lymphocytic leukemia – real world data from the registry of the German CLL Study Group

Intensity of Withdrawal Symptoms During Opioid Taper in Patients with Chronic Pain—Individualized or Fixed Starting Dosage?

Confusing and Substantially Overinterpreted

Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial

Impact of the changing landscape of induction therapy prior to autologous stem cell transplantation in 540 newly diagnosed myeloma patients: a retrospective real-world study

Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions

Long-term effectiveness of topical analgesics

Induction with Bortezomib Melphalan and Prednisolon (VMP) Is Associated with Unexpectedly High Discontinuation Rate in Elderly Multiple Myeloma Patients: First Analysis of the German Maintenance (GERMAIN) Trial

Frailty impairs the feasibility of induction therapy but not of maintenance therapy in elderly myeloma patients: final results of the German Maintenance Study (GERMAIN)

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas” (PETAL) trial

Medication compliance in patients with chronic pain

Bendamustine, lenalidomide and dexamethasone (BRd) has high activity as 2nd‐line therapy for relapsed and refractory multiple myeloma – a phase II trial

Suchergebnisse filtern